Release Date: 2023-09-14

Stem Cell, Experimental Animals and Cell Culture Studies in Diabetes

Rahim Kocabas (Author), Hale Koksoy (Author)

Release Date: 2023-09-14

Research involving stem cells, experimental animals, and cell culture studies in diabetes aims to explore potential therapeutic avenues and deepen our understanding of disease mechanisms. Stem cell research holds promise in regenerative medicine for diabetes, focusing on the differentiation of stem cells into insulin-producing beta cells or enhancing their survival and function post-transplantation. Experimental animal [...]

Media Type

  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inCurrent Multidisciplinary Approach to Diabetes Mellitus Occurrence Mechanism
First Page79
Last Page93
DOIhttps://doi.org/10.69860/nobel.9786053359104.8
ISBN978-605-335-910-4 (PDF)
LanguageENG
Page Count15
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

Research involving stem cells, experimental animals, and cell culture studies in diabetes aims to explore potential therapeutic avenues and deepen our understanding of disease mechanisms. Stem cell research holds promise in regenerative medicine for diabetes, focusing on the differentiation of stem cells into insulin-producing beta cells or enhancing their survival and function post-transplantation. Experimental animal models, such as rodents and non-human primates, are crucial for studying disease pathogenesis and testing novel therapies. These models help researchers investigate the impact of genetic, environmental, and therapeutic interventions on glucose metabolism, insulin sensitivity, and diabetic complications. Additionally, cell culture studies provide insights into cellular mechanisms underlying insulin resistance, beta cell dysfunction, and the effects of various pharmacological agents or genetic manipulations. Integrating findings from stem cell research, animal models, and cell culture studies facilitates the development of innovative treatments, personalized therapies, and preventive strategies for diabetes mellitus.

Rahim Kocabas (Author)
Assistant Professor, Karamanoglu Mehmetbey University
https://orcid.org/0000-0001-8006-284X

Hale Koksoy (Author)
Assistant Professor, Karamanoglu Mehmetbey University
https://orcid.org/0000-0001-5950-1449

  • Lotfy M, Adeghate J, Kalasz H, Singh J, Adeghate E. Chronic Complications of Diabetes Mellitus: A Mini Review. Current diabetes reviews. 2017;13(1):3-10.

  • Sapra A, Bhandari P. Diabetes Mellitus. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2023, StatPearls Publishing LLC.; 2023.

  • Helman A, Melton DA. A Stem Cell Approach to Cure Type 1 Diabetes. Cold Spring Harbor perspectives in biology. 2021;13(1).

  • Kleinert M, Clemmensen C, Hofmann SM, Moore MC, Renner S, Woods SC, et al. Animal models of obesity and diabetes mellitus. Nature reviews Endocrinology. 2018;14(3):140-62.

  • Chhoun JM, Voltzke KJ, Firpo MT. From cell culture to a cure: pancreatic β-cell replacement strategies for diabetes mellitus. Regenerative medicine. 2012;7(5):685-95.

  • Sirhan W, Piran R. Current Approaches in Diabetes Treatment and Other Strategies to Reach Normoglycemia. Current topics in medicinal chemistry. 2020;20(32):2922-44.

  • Siehler J, Blöchinger AK, Meier M, Lickert H. Engineering islets from stem cells for advanced therapies of diabetes. Nature reviews Drug discovery. 2021;20(12):920-40.

  • Eizirik DL, Pasquali L, Cnop M. Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nature reviews Endocrinology. 2020;16(7):349-62.

  • Messerli FH, Grossman E, Michalewicz L. Combination therapy and target organ protection in hypertension and diabetes mellitus. American journal of hypertension. 1997;10(9 Pt 2):198s-201s.

  • Padhi S, Nayak AK, Behera A. Type II diabetes mellitus: a review on recent drug based therapeutics. Biomedicine & pharmacotherapy = Biomedicine & pharmacotherapy. 2020;131:110708.

  • Memon B, Abdelalim EM. Stem Cell Therapy for Diabetes: Beta Cells versus Pancreatic Progenitors. Cells. 2020;9(2).

  • Päth G, Perakakis N, Mantzoros CS, Seufert J. Stem cells in the treatment of diabetes mellitus - Focus on mesenchymal stem cells. Metabolism: clinical and experimental. 2019;90:1-15.

  • Rees DA, Alcolado JC. Animal models of diabetes mellitus. Diabetic medicine : a journal of the British Diabetic Association. 2005;22(4):359-70.

  • Al-Awar A, Kupai K, Veszelka M, Szűcs G, Attieh Z, Murlasits Z, et al. Experimental Diabetes Mellitus in Different Animal Models. Journal of diabetes research. 2016;2016:9051426.

  • Papoz A, Clément F, Laporte C, Tubbs E, Gidrol X, Pitaval A. [Generating pancreatic islets organoids: Langerhanoids]. Medecine sciences : M/S. 2022;38(1):52-8.

  • Tse HM, Gardner G, Dominguez-Bendala J, Fraker CA. The Importance of Proper Oxygenation in 3D Culture. Frontiers in bioengineering and biotechnology. 2021;9:634403.

  • Dayem AA, Lee SB, Kim K, Lim KM, Jeon TI, Cho SG. Recent advances in organoid culture for insulin production and diabetes therapy: methods and challenges. BMB reports. 2019;52(5):295-303.

  • Phillips A, Janssen U, Floege J. Progression of diabetic nephropathy. Insights from cell culture studies and animal models. Kidney & blood pressure research. 1999;22(1-2):81-97.

  • Li H, Zhu H, Ge T, Wang Z, Zhang C. Mesenchymal Stem Cell-Based Therapy for Diabetes Mellitus: Enhancement Strategies and Future Perspectives. Stem cell reviews and reports. 2021;17(5):1552-69.

  • Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, et al. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebocontrolled clinical trial. Stem cell research & therapy. 2022;13(1):264.

  • Donzelli E, Scuteri A. Mesenchymal Stem Cells: A Trump Card for the Treatment of Diabetes? Biomedicines. 2020;8(5).

  • Zhang W, Ling Q, Wang B, Wang K, Pang J, Lu J, et al. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes. Stem cell research & therapy. 2022;13(1):406.

  • Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. Islet-associated macrophages in type 2 diabetes. Diabetologia. 2009;52(8):1686-8.

  • Anders HJ, Huber TB, Isermann B, Schiffer M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nature reviews Nephrology. 2018;14(6):361-77.

  • Banihani S, Swedan S, Alguraan Z. Pomegranate and type 2 diabetes. Nutrition research (New York, NY). 2013;33(5):341-8.

  • Loretelli C, Assi E, Seelam AJ, Ben Nasr M, Fiorina P. Cell therapy for type 1 diabetes. Expert opinion on biological therapy. 2020;20(8):887-97.

  • Salib A, Cayabyab F, Yoshihara E. Stem Cell-Derived Islets for Type 2 Diabetes. International journal of molecular sciences. 2022;23(9).

  • de Klerk E, Hebrok M. Stem Cell-Based Clinical Trials for Diabetes Mellitus. Frontiers in endocrinology. 2021;12:631463.

  • Shakya A, Chaudary SK, Garabadu D, Bhat HR, Kakoti BB, Ghosh SK. A Comprehensive Review on Preclinical Diabetic Models. Current diabetes reviews. 2020;16(2):104-16.

  • Jayasinghe M, Prathiraja O, Perera PB, Jena R, Silva MS, Weerawarna PSH, et al. The Role of Mesenchymal Stem Cells in the Treatment of Type 1 Diabetes. Cureus. 2022;14(7):e27337.

onix_3.0::thothThoth ONIX 3.0
onix_3.0::project_museProject MUSE ONIX 3.0
onix_3.0::oapenOAPEN ONIX 3.0
onix_3.0::jstorJSTOR ONIX 3.0
onix_3.0::google_booksGoogle Books ONIX 3.0
onix_3.0::overdriveOverDrive ONIX 3.0
onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
csv::thothThoth CSV
json::thothThoth JSON
kbart::oclcOCLC KBART
bibtex::thothThoth BibTeX
doideposit::crossrefCrossRef DOI deposit
onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
marc21record::thothThoth MARC 21 Record
marc21markup::thothThoth MARC 21 Markup
marc21xml::thothThoth MARC 21 XML

Share This Chapter!